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The fast developing international trade of products based on traditional knowledge
and their value chains has become an important aspect of the ethnopharmacological
debate. The structure and diversity of value chains and their impact on the phytochemical
composition of herbal medicinal products, as well as the underlying government
policies and regulations, have been overlooked in the debate about quality problems
in transnational trade. Rhodiola species, including Rhodiola rosea L. and Rhodiola
crenulata (Hook. f. & Thomson) H. Ohba, are used as traditional herbal medicines.
Faced with resource depletion and environment destruction, R. rosea and R. crenulata
are becoming endangered, making them more economically valuable to collectors and
middlemen, and also increasing the risk of adulteration and low quality.Rhodiola products
have been subject to adulteration and we recently assessed 39 commercial products
for their composition and quality. However, the range of Rhodiola species potentially
implicated has not been assessed. Also, the ability of selected analytical techniques in
differentiating these species is not known yet. Using a strategy previously developed by
our group, we compare the phytochemical differences among Rhodiola raw materials
available on the market to provide a practical method for the identification of different
Rhodiola species from Europe and Asia and the detection of potential adulterants.
Nuclear magnetic resonance spectroscopy coupled with multivariate analysis software
and high performance thin layer chromatography techniques were used to analyse
the samples. Rosavin and rosarin were mainly present in R. rosea but also in Rosea
sachalinensis Borris. 30% of the Rhodiola samples purchased from the Chinese market
were adulterated by other Rhodiola spp. The utilization of a combined platform based
on 1H-NMR and HPTLC methods resulted in an integrated analysis of different Rhodiola
species. We identified adulteration at the earliest stage of the value chains, i.e., during
collection as a key problem involving several species. This project also highlights the
need to further study the links between producers and consumers in national and
trans-national trade.
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INTRODUCTION
While medicinal plants and spices have been traded for centuries
on a global scale, the fast developing international trade of
products now includes a large number of species which are used
based on local and traditional knowledge and practice. The value
chains of such products are starting to become an important topic
in the ethnopharmacological debate. The structure and diversity
of value chains, as well as their impact on the phytochemical
composition of herbal medicinal products (HMPs) has been
overlooked in quality issues in transnational trade. Different
government policies and regulations governing trade in herbal
medicinal products impact on such value chains.
Medicinal Rhodiola species, including Rhodiola rosea L. and
Rhodiola crenulata (Hook. f. & Thomson) H. Ohba (Figure 1),
have been used widely in Europe and Asia as traditional herbal
medicines with numerous claims for their therapeutic effects.
Faced with resource depletion and environment destruction,
R. rosea and R. crenulata are becoming endangered, making them
more economically valuable to collectors and middlemen, and
also increasing the risk of adulteration and low quality. Poor
quality and adulterated R. rosea products have been previously
reported (Booker et al., 2015; Xin et al., 2015) and this paper
investigates some aspects of the value chains that leads to the
production of such products.
Adulteration of R. rosea products with R. crenulata has been
previously reported but our fieldwork investigations suggested
that other species may be implicated, and particularly Rhodiola
sachalinensis, another species that appears to contain rosavins
(the main marker compounds used for the identification of
R. rosea).
The genus Rhodiola (Crassulaceae) comprises ∼90 species of
succulent and herbaceous perennial plants, which mainly show
a circumpolar distribution across the northern hemisphere (Xia
et al., 2005; Lu and Lan, 2013). Rhodiola species usually grow
in mountainous areas such as rock ledges, precipices, tundra,
brooks, and river banks (Zhu and Lou, 2010).
Ethnopharmacological Importance of Key
Rhodiola Species
In Europe and North America, Sedum roseum (L.) Scop.
(commonly named under its synonym R. rosea L.) is the most
well-known and widely used among the different species. It is also
known as golden root, or artic root which reputedly demonstrates
the economic importance and the geographical distribution of
the plant. It has a rich history of traditional use in Russia, Europe
and Asia with various uses according to the region (e.g., as shown
in Table 1).
In Europe, the first documented medicinal use of R. rosea
can be traced back to Dioscorides in 77 A.D. (Brown et al.,
2002). In C. v. Linne’s Materia Medica, the root of R. rosea
was recommended for several conditions such as headaches,
“hysteria,” hernias and discharges (C. v. Linne, 1749 in Panossian
et al., 2010). Throughout the years, it has appeared in many
Abbreviations: TCM, Traditional Chinese Medicine; NMR, Nuclear magnetic
resonance; HPTLC, High performance thin layer chromatography; spp, Species.
pharmacopeias and medicinal books of different countries such
as Sweden, France, Norway, Germany, Iceland, Estonia, and
Russia (Brown et al., 2002; Alm, 2004; Panossian et al., 2010;
Shikov et al., 2014).
In China, 73 different Rhodiola species have been reported,
mainly in the northwest and southwest regions such as Tibet and
the Sichuan province. The adaptogenic and tonic properties of
the Rhodiola plants have been widely used in traditional Chinese
and Tibetan medicine (Li and Zhang, 2008). They are generally
referred to with the Pinyin name Hong Jing Tian红景天[red (or
glorious) view of heaven] with slight alterations for each species
(Table 2).
R. crenulata can be traced back to Tibetan medicine books
including “The Four Medical Tantras” (rgyud-bzhi in Tibetan,
Si Bu Yi Dian in Chinese), Yue Wang’s Classical Medicinal
Book (Somaratsa in Tibetan, Yue Wang Yao Zhen in Chinese),
and Jing Zhu Materia Medica [Shel Gong Shel Phreng in
Tibetan, Jing Zhu Ben Cao in Chinese (Lu and Lan, 2013)]. It
is used for treatment of cough, hemoptysis, pneumonia, and
abnormal vaginal discharge. In Traditional Chinese Medicine
(TCM), it has effects of nourishing qi as well as promoting
blood circulation and is mainly prescribed for qi deficiency
and blood stasis (QDBS), stroke, hemiplegia, and fatigue. It
is commonly used in China and Tibet for treating altitude
sickness.
Phytochemical and Pharmacological
Research
Research on the phytochemistry and pharmacology of Rhodiola
spp. was initiated in the 1960s in the Soviet Union and
Scandinavia, mainly focusing on R. rosea (Brown et al., 2002).
After the turn of the century the interest in this plant spread
globally. Intensive phytochemical research led to the detection
of known and novel compounds in R. rosea and related species
(Ma et al., 2006; Yousef et al., 2006). Between 2000 and 2015 an
increased number of publications stemming from Asian research
groups have focused on the detection of novel compounds from
Rhodiola species, usually in combination with their respective
pharmacological assessments (Fan et al., 2001; Nakamura et al.,
2007, 2008).
There are more than a few hundred pharmacological studies
on medicinal Rhodiola species (mainly on R. rosea) that show
a wide range of activities reflecting their diverse traditional
use. They possess adaptogenic and stress-protective (neuro-
cardio and hepato protective) and antioxidant effects, as well as
stimulating effects on the central nervous system, including on
cognitive functions such as attention, memory and learning; anti-
fatigue effects; antidepressive and anxiolytic effects; endocrine
activity normalizing; and life-span increasing effects (Aslanyan
et al., 2010; Sarris et al., 2011; Panossian et al., 2013).
The main active compounds are reputedly phenylpropanoids
(rosavin, rosarin, rosin) and phenylethanoids (salidroside and
tyrosol).
Quality Issues of Medicinal Rhodiola spp.
Rhodiola roots and rhizomes are highly valuable products traded
at an international level. Since the majority of R. rosea and R.
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FIGURE 1 | Rhodiola species. (A) R. rosea; (B) R. crenulata. Photos taken by A. Booker, Sichuan-Tibet border, June, 2015.
TABLE 1 | Traditional uses of R. rosea in different regions.
Region Use References
Russia • Escalation of physical endurance
• Remedy against fatigue and high
altitude sickness
• Aphrodisiac
Shikov et al.,
2014; Alm,
2004
Norway • Astringent
• Cure for scurvy
• Remedy against hair-loss and urinary
tract disorders
Alm, 2004
Iceland and Denmark • Alleviation of headaches Alm, 2004
France • Stimulant
• Astringent
Panossian
et al., 2010
Alaska • Cure for sores
• Remedy against tuberculosis
Alm, 2004
Mongolia • Remedy against tuberculosis
• Anticancer
• Escalation of physical endurance
• Treatment for lung inflammation
Brown et al.,
2002; World
Health
Organization,
2013
crenulata raw material supplied still comes from wild-collection,
their intensive collection leads to scarcity (Galambosi, 2006; Lu
and Lan, 2013).
Herbal preparations of Rhodiola species (mainly R. rosea)
are extensively utilized around the globe. There is an increasing
number of commercial products available on the American,
Asian and European markets, either as food supplements
or herbal medicines. R. rosea herbal monographs have been
included in many Pharmacopeias worldwide. On the other
hand, R. crenulata is the only species used medicinally in TCM
(Table 3).
Due to this rapid increase of Rhodiola raw material demand,
other Rhodiola species such as R. fastigiata, R. sachalinensis,
TABLE 2 | Examples of the similar Pin Yin names of different Rhodiola
species in China.
Scientific name Pin Yin name
R. rosea L. Qiang Wei (rose smell) Hong Jing
Tian
R. sachalinensis Borris. Gao Shan (high mountain) Hong
Jing Tian
R. quadrifida (Pall.) Fisch. & C.A.Mey Si Lie (four split) Hong Jing Tian
R. crenulata (Hook. f. & Thomson) H. Ohba Da Hua (big flower) Hong Jing
Tian
R. yunnanensis (Franch.) S.H. Fu Yunnan (From Yunnan) Hong
Jing Tian
R. kirilowii (Regel) Maxim. Xia Ye (narrow leaf) Hong Jing
Tian
R. fastigiata (Hook. f. & Thomson) S.H. Fu Chang Bian (clustered) Hong
Jing Tian
R. quadrifida, Rhodiola sacra (Prain ex Hamet) S. H. Fu
and Rhodiola serrata H. Ohba have been sold on the
market (Xin et al., 2015). Since there is not any consistent
worldwide quality control programme, inadequate quality
assessment of Rhodiola spp. is a common issue. This raises
concerns about possible adulteration and misidentification
issues. The lack of genuine drug material, confusion over
the Chinese Pin Yin name of the drug when sourcing from
China and accidental or deliberate adulteration during the
manufacturing stage may contribute to low quality of final
products.
The analytical techniques currently available focus on
identifying R. rosea or R. crenulata through chromatographic
methods. Other species of Rhodiola have generally not been
considered. R. sachalinensis presents a particular problem as it
may contain similar marker compounds to R. rosea (and some
sources suggest that it is the same species—see http://www.kew.
org/mpns-portal).
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TABLE 3 | Generation of Rhodiola spp. recorded in selected
pharmacopeias and publications.
Pharmacopeia/ Recorded Medicinal Herbal
publication Rhodiola species use part product
Department of Health
and Ageing, Australian
Government
Rhodiola rosea Root (Rhizome) Dry extract
Committee on Herbal
Medicinal Products,
2012
Rhodiola rosea Rhizoma et radix Extract
United States
Pharmacopeia (32th
Edition)
Rhodiola rosea Rhizoma et radix Dry extract,
tincture
Chinese
Pharmacopoeia, 2010
Rhodiola crenulata Rhizoma et radix Extract
Russian
Pharmacopoeia (12th
Edition)
Rhodiola rosea Rhizoma et radix Extract
Integrated Analytical Platform Approach
NMR-Based Metabolomics
NMR-based metabolic fingerprinting has been used in the
analysis of numerous food and medicinal species focusing
on their quality assurance as well as their pharmacology.
Such comparative studies include Danggui [Angelica sinensis
(Oliv.) Diels] and Engelwurz/European Angelica (Angelica
archangelica L.; Li et al., 2014). Metabolomic differences between
different Tussilago farfara L. accessions (Zhi et al., 2012)
and different Salvia miltiorrhiza Bunge production sites (Jiang
et al., 2014) were also studied by NMR fingerprinting coupled
with multivariate analysis. Compared to GC-MS and LC-MS,
NMR has some advantages such as non-selectiveness, high
reproducibility, and good stability (Simmler et al., 2014). At
the same time, structural information on metabolites can
be obtained from NMR directly. Therefore, NMR can be
regarded as an ideal choice for chemical comparison and
identification of the phytochemical differences of medicinal
plants.
HPTLC
Since the NMR-metabolomic approach is not a validated
pharmacopoeial method, there is a need to be compared
to a standard method like high performance thin layer
chromatography (HPTLC). This method is widely used for the
authentication and quality control of herbal substances (Reich
et al., 2008). Compared to NMR-based metabolic fingerprinting,
HPTLC could be highly effective with relatively lower price
(Booker et al., 2014). HPTLC can also be helpful for the
identification of specific compounds. Therefore, we chose these
two complementary approaches in this study.
A third analysis strategy using DNA bar coding was used
to help verify some of the samples (details are given in the
Supplement S2).
MATERIALS AND METHODS
Sampling and Preparation of Plant Material
Forty-two batches of Rhodiola market samples (i.e., not
authenticated) were collected between October 2014 and
January 2015 from different suppliers including retail outlets,
The internet, pharmaceutical companies in seven different
locations (Beijing, Guangdong, Qinghai, Anhui, Hebei, Jilin,
and Hong Kong SAR) and in China, Germany and Russia.
These raw-material samples were mainly labeled as R. rosea,
R. crenulata, R. sachalinensis, and R. quadrifida. 18 batches
of authenticated plant material were provided by Agroscope
Institute (Switzerland). The samples were rhizomes of R. rosea
plants propagated from different wild Swiss populations
(Mattmark, Carrasino, and Nomnon) or botanical gardens
(Switzerland and Germany). In addition, authenticated R. rosea
samples which were grown from seeds or provided to the
institute by Dr. Bertalan Galambosi were also included. Lastly,
in June 2015, samples of R. crenulata and R. fastigiata roots
and rhizomes were collected from Garze, Sichuan, China
(altitude 4500 m). These samples were authenticated by
Professor Shuyuan Li, (Guangdong Pharmaceutical University,
Guangzhou, China). Botanical reference materials (BRMs) for
R. rosea, R. crenulata, and R. sachalinensiswere obtained from the
National Institute of Food and Drug Control (NIFDC, China),
Dr. William Schwabe (Germany) and Agroscope (Switzerland).
BRMs for R. quadrifida and R. fastigiata were provided
by Professor Alexander Shikov (Saint-Petersburg Institute of
Pharmacy, Russia) and Dr. Anthony Booker (UCL School of
Pharmacy). R. fastigiata was authenticated by Professor Shuyuan
Li (Guangdong Pharmaceutical University, Guangzhou, China).
All the collected samples were deposited in the herbarium
of the UCL School of Pharmacy (London, UK). A detailed
description of the investigated samples including their origins
and representative symbols are provided in Supplement (S1).
Crude root samples were ground to powder using a household
grinder (EK1665ROFOB, Salter, UK) and sieved (0.70mmmesh).
All the powder samples were kept in 1.5 ml tubes (Eppendorf
AG.) at 4◦C until use.
Solvents, Reagents, and Reference
Compounds
Deuterium oxide (D2O), methanol-d4 (99.8% D, MeOD),
dimethyl sulfoxide-d6 (DMSO-d6), and tetramethylsilane (TMS)
were obtained from Cambridge Isotope Laboratories Inc.
(Andover, MA). Salidroside, gallic acid, rosarin, and rosavin
were purchased from Sigma-Aldrich Chemicals (St Luis, USA).
Tyrosol was purchased from Acros organics (New Jersey, US).
Water used in this study was purified by using ULTRAPURE
water system (Millipore, Germany). All other chemicals were of
analytical grade.
1H-NMR Spectroscopy
Sample Preparation
Nine-hundred microliter of MeOD-d4 was added for extraction.
The samples were vortexed (Rodamixer, UK) for 30 s and
sonicated at an ultrasound bath (Fisher, XB22, UK) for 10
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min. The solutions were centrifuged for 10 min at 14,000 rpm
(EBA21, Hettich, Faust Laborbedarf AG, Germany). Six-hundred
microliter of supernatant was transferred to a 5 mm diameter
NMR spectroscopy tube and the samples were submitted for
NMR spectroscopic analysis. The one and two dimensional
1H-NMR spectra were recorded on Brucker Avance 500 MHz
spectrometer (Bruker Analytic, Germany), which was equipped
with a QNP (31P, 13C, 15N, and 1H) 5mm cryoprobe. The
acquisition parameters were: size of the spectra 64 k data points,
line broadening factor= 0.16Hz, pulse width (PW)= 30 degrees,
and the relaxation delay d1 = 1 s. The acquisition temperature
was 298 K.
In order to assess the coherence of the results obtained, two
samples from the same batch were subjected to NMR analysis on
the different days of examination. To minimize the error caused
by root selection during sample grinding, any samples weighing
more than 500 g were analyzed twice.
Data Analysis
The resulting spectra were manually phased and auto-baseline
corrected by Topspin 3.2 (Bruker, Germany) for organic
fractions. Signals between δ 5.20–4.40 ppm and δ 3.35–3.22 ppm
were removed prior to statistical analysis due to the presence of
methanol-d4. The total area of peaks (δ 10.00–0.00 ppm) was
integrated into small (0.04 ppm) buckets by bucketing (binning)
function using AMIX or ACD-Labs in order to generate a
number of integrated regions of the data set. The buckets
obtained were then imported to Microsoft EXCEL (2013) where
the samples were re-labeled and their species information was
added.
Principal component analysis (PCA) was performed with
SIMCA-P 13.0 (Umetrics, Umeå, Sweden) for metabolomic
analysis of the generated dataset. Scaling mode of Pareto (Par)
and Unit Variance (UV) were tested to optimize the analysis
model.
HPTLC
Sample Preparation
One milliliter of ethanol was added to 50mg of weighed samples
for extraction. The solutions were then mixed on a rotary mixer
(Rodamixer, UK) for 30 s, sonicated in an ultrasound bath
(Fisher, XB22, UK) for 10 min and centrifuged for 10 min at
14,000 rpm. The supernatant was used for HPTLC analysis. The
reference standard solutions of salidroside, rosarin, rosavin, gallic
acid, and tyrosol were prepared at a concentration 1 mg/ml in
methanol. Both the reference material and the test samples were
stored at 4◦C.
Data Analysis
Samples were applied to the plates as bands 8 mm wide by using
Linomat 5 semi-automatic applicator with 100 µl syringe. The
space between bands was 2.0 mm and the rate of application was
90 nl·s−1. The number of tracks per plate was 15, and 5 µl of
standard and sample solutions were applied.
The temperature and relative humidity were controlled to
21–24◦C and 33%, respectively. Ten milliliter of solvent was
poured into the right inlet for development and 25ml of
solvent was poured into the left inlet for saturation. Plates were
previously air dried for 10 s and developed in a 20 × 10 cm
twin-trough chamber (Analtech, USA) lined with Whatman
filter paper (20 × 10 cm) and saturated with mobile phase
(Ethylacetate, methanol, water, formic acid (77:13:10:2) vapor for
20min. The development distance was 70.0mm from the lower
edge.
The developed plates were derivatised by dipping in sulfuric
acid reagent, using a CAMAG chromatogram immersion device
and heated at 100◦C on a plate heater for 5 min. Sulfuric acid
reagent was prepared with a procedure as follow: 20ml sulfuric
acid was carefully added to 180 ml ice-cold methanol and mixed.
The plates were visualized using CAMAG visualizer under white
light, UV 254 nm and at UV 366 nm, photographed and uploaded
to HPTLC computer software (VisionCats).
RESULTS AND DISCUSSION
1H-NMR and Multivariate Statistical
Analysis
By incorporating the whole region (0–10 ppm) and Pareto (Par)
scaling, a significant clustering is observed in R. rosea samples
(Figure 2). R. rosea can be differentiated distinctly from the rest
of the species based on their principal component variability.
According to the spectra of the species (Figure 3), the
aromatic region (6–8 ppm) is dominated by the main marker
compounds (rosavin and salidroside). Hence, this region was
analyzed independently using Par scaling (Figure 4). Based
on the scores plot produced, Rhodiola species were separated
more clearly compared to the scores plot of the whole
region.
R. crenulata and R. quadrifida were also separated from the
rest of the species. However, in this model they were clustered
together. This suggests that there is no crucial metabolomic
difference between them in the aromatic region. At this point
it was considered important to visually inspect the spectra of
the BRM’s and detect any differences that might be lost with
the integration of the data. R. crenulata BRM has an additional
quartet at 6 ppm not detected in the rest of the species. This
quartet can also be found in all the other R. crenulata samples
investigated (figures not shown).
Therefore, an effective separation between R. crenulata and
R. quadrifida samples can be accomplished by combining the
PCA results with the detection of the additional peaks on the 1H-
NMR spectra only present in R. crenulata samples between 5 and
6 ppm.
We also studied the group-pair comparisons in PCA model
with Par scaling (Figure 5). The score plots showed that Rhodiola
species separated well (A: R. crenulatawith other Rhodiola species;
B: R. rosea with other Rhodiola species; C: R. crenulata with
R. rosea).
The main differences were between δ 7.5–7.3 ppm (PC1) and
δ 7.0–6.8 ppm (PC2). The chemical shift of the main variable
metabolites were mainly rosavin, rosarin, and cinnamyl alcohol
derivatives.
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FIGURE 2 | Scores plot of five different species of Rhodiola (R. rosea, R. crenulata, R. quadrifida, R. sachalinensis, R. fastigiata), showing principle
component 1 and principal component 2.
FIGURE 3 | 1H-NMR spectra of the reference compounds, salidroside and rosavin, together with the spectra of botanical reference material. 1: R.
fastigiata, 2: R. quadrifida, 3: R. crenulata, 4: R. sachalinensis, 5: R. rosea, 6: rosavin, and 7: salidroside. (From bottom to top) (A) Whole region (0–10 ppm); (B)
aromatic region (6–8 ppm).
The metabolites detected were elucidated by the analyses
of the 1H-NMR spectra as well as the comparison with
the reference compounds, together with the in-house
NMR chemical shift database (Mudge et al., 2013; Luo
et al., 2015). The summary of the assignment of 1H-NMR
spectral peaks obtained from the R. rosea, R. crenulata,
and R. sachalinensis BRM extracts are provided in
Supplement (S3).
HPTLC Analysis
The band position and visibility of the standards rosavin,
rosarin, and salidroside (Figure 6) appear with characteristic
colors and increasing retention factors (Rfs) 0.19, 0.26, and 0.31,
respectively. Under UV light 254 nm, salidroside is not visible.
Under 366 nm, after derivitisation with sulfuric acid, rosavin
and rosarin appear as pale pink bands and salidroside as a
green one.
Frontiers in Pharmacology | www.frontiersin.org 6 August 2016 | Volume 7 | Article 254
Booker et al. Comparative Quality Study of Rhodiola Species
FIGURE 4 | Scores plot of Rhodiola samples using the aromatic 1H-NMR region and Pareto scaling.
FIGURE 5 | Score plots of group comparison between Rhodiola species. (A) R. crenulata (red) with other Rhodiola spp. (blue); (B) R. rosea (green) with other
Rhodiola spp. (blue); (C) R. crenulata (red) with R. rosea (green).
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FIGURE 6 | Left: HPTLC results of standard compounds under UV 254 nm (rosavin Rf = 0.19, rosarin Rf = 0.26, gallic acid Rf = 0.58); Right: HPTLC
results of standard compounds under UV 366 nm, after derivatisation with sulfuric acid (rosavin Rf = 0.19, rosarin Rf = 0.26, salidroside Rf = 0.31,
gallic acid Rf = 0.58, tyrosol Rf = 0.76).
FIGURE 7 | HPTLC results for all Rhodiola market samples, mobile phase [Ethylacetate, methanol, water, formic acid (77:13:10:2)].
Gallic acid shows good visibility under UV 254 nm, while it is
not easily detected under UV 366 nm at a dark blue back-round.
Tyrosol is visible in 254 nm but less clear in 366 nm.
The raw plant material obtained from the market was also
studied by our HPTLC method (list of samples in Supplement
S4). Under UV 254 nm (Figure 7), there were two obvious bands
among these samples (Rf = 0.27 and 0.48). However, due to lack
of reference standards, their identity remains unknown. Further
studies need to be conducted using NMR and LC-MS. The
majority of the samples investigated contained concentrations of
tyrosol similar to the standard raw material used (R24, R30, and
R31). Samples R1–R6 contained lower levels of this compound
possibly due to their longer storage time. Therefore, tyrosol could
be considered as a marker to study duration of Rhodiola storage.
It was also found that only five samples (R9, R25, R58, R59, and
R24) contained high levels of rosavin, which turned out to be the
ones from R. rosea. Moreover, this result can also be verified by
the NMR results (Figure 5). However, it is not evident whether
there is adulteration of R. sachalinensis in R. rosea since their
metabolites are similar.
Under UV 366 nm after derivatisation eight samples (R1, R5,
R6, R15, R27, R32, R61, and R64) had a low concentration of
salidroside (Rf= 0.31). These samples could have been kept for a
long time after collection and the salidroside content could have
decreased due to lack of a good storage environment.
Combining the results of HPTLC and 1H-NMR multivariate
statistical analysis, we also analyzed the adulteration rate among
all the market samples (Supplement, S4).
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Thirty percent of the Rhodiola samples collected from the
market were not, as declared on the label, i.e., either R. rosea
or R. crenulata. Some R. rosea samples were also being sold as
R. crenulata. 47.7% of raw material samples were not labeled
properly and their species information were not clearly illustrated
to customers. This highlights a clear lack of proper local
government policies and good quality control strategies.
According to our study, different Rhodiola species (including
R. rosea and R. crenulata) can be found in the Chinese market.
However, they are neither sold separately nor well-identified.
Therefore, there is a high potential of adulteration and
substitution among these species.
Qualitative and Quantitative Analysis of
Mixtures
Since in the value chain, mixing of batches and, therefore,
potentially also of species, is of major concern, the possibility
of qualitatively and quantitatively detecting plant mixtures
was also investigated. The additional species chosen for this
study was R. crenulata which is considered to be the most
common adulterant of R. rosea. The selected BRMs were weighed
individually in different proportions and then added together in
an Eppendorf reaction tube. The rest of the sample preparation
was identical to the methodology for the 1H-NMR spectroscopy.
The samples were renamed as seen in Table 4. After the
acquisition of the spectra, they were baseline and phase corrected
and zeroed to the TMS peak in Topspin 3.2.
TABLE 4 | 1H-NMR-based detection of plant mixtures by.
Sample name Mg of R. rosea BRM Mg of R. crenulata BRM
RR100 100 00
RR80RC20 80 20
RR60RC40 60 40
RR40RC60 40 60
RR20RC80 20 80
RC100 00 100
In all samples, the salidroside peak intensity remains almost
the same since this constituent is present in both species. The
peaks of rosavin are gradually decreasing with the addition of
R. crenulata, whereas the characteristic quartet at 6 ppm due to
the presence of an unknown compound is increasing with the
addition of R. crenulata and it is not detected in R. rosea at all
(Figure 8).
The acquired spectra were bucketed using Amix and only
focused on this region (6 ppm). When the whole quartet was
FIGURE 9 | Calibration curve showing the bucket value of the peak vs.
the percentage of R. crenulata within a mixture of R. crenulata and
R. rosea.
TABLE 5 | Sample preparation for the detection of plant mixtures by
HPTLC.
R. rosea 100% RR100 R. rosea BRM 5 µL
R. rosea 80% and R. crenulata 20% RR80 R. rosea BRM 4 µL
R. crenulata BRM 1 µL
R. rosea 60% and R. crenulata 40% RR60 R. rosea BRM 3 µL
R. crenulata BRM 2 µL
R. rosea 40% and R. crenulata 60% RR40 R. rosea BRM 2 µL
R. crenulata BRM 3 µL
R. rosea 20% and R. crenulata 80% RR20 R. rosea BRM 1 µL
R. crenulata BRM 4 µL
R. crenulata 100% RC100 R. crenulata BRM 5 µL
FIGURE 8 | 1H-NMR spectra of the whole region (left) and the aromatic region (right) of the R. rosea and R. crenulata mixtures.
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FIGURE 10 | HPTLC fingerprints of all R. rosea and R. crenulata mixtures under UV 254 nm (tracks 1–6), white light and SAR (tracks 7–12), and UV
366nm and SAR (tracks 13–18).
integrated into a single bucket, the observed increase of its
intensity was not adequately represented. Therefore, the bucket
size used changed to 0.002 ppm and only incorporated the first
peak of the quartet (6.0028–6.0048 ppm). The buckets obtained
from Amix were transferred into Excel, where the relationship
between the bucket value and the percentage of R. crenulata in
the mixture was expressed graphically as a calibration curve. The
bucket value of the respective peak is increasing in a linear mode
(Figure 9).
Similar results can also be obtained with HPTLC analysis. The
HPTLC fingerprints produced consist of the over-spotted BRM
extracts in different volumes as seen in Table 5. The final volume
applied was 5 µl.
As seen in Figure 10, when the loading volume of the
R. rosea decreases, the representative markers of this species
(rosavin and rosarin) decrease as well. However, the band for
salidroside, (since it occurs in both species) remains almost
the same.
By gradually increasing the R. crenulata proportion,
several bands gradually appear above salidroside that could
potentially be used as markers for the qualitative and semi-
quantitative HPTLC analysis of mixtures of these two
Rhodiola species. Further work needs to be carried out
to determine the identity and species-specificity of these
compounds.
CONCLUSIONS
This study provided a method for distinguishing five different
species ofRhodiola and suggests possiblemethods for quantifying
different species within mixtures. The metabolomic and
phytochemical differences between these different species has
been demonstrated through NMR spectroscopy and HPTLC
analysis. Species represented with only a small number of
samples will need further investigation in order to accurately
define their chemical characteristics.
There is a need to study the links between producers and
consumers especially when in trans-national trade and re-enforce
the hypothesis that poor quality and adulterated products can be
products of poorly governed value chains, particularly at the early
stages of supply. Moreover, through the establishment of well-
controlled and well-managed value chains it is possible to better
prevent accidental or deliberate contamination and adulteration
from occurring.
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